Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
ViaDerma Inc
VDRM
Healthcare
Biotechnology
ViaDerma, Inc. is a specialty pharmaceutical company committed to bringing new products to market and licensing its transdermal drug delivery technology solutions. The Company’s lead product is a topical antibiotic, which is focused on being sold under the brand name Vitastem. The Company also has products in development in the fields: anti-aging skin care, pain management, hair-loss, and...
toenail fungus. The products are based on a patent pending delivery system technology that allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy. The Company utilizes a specific trade secret formulation system in the manufacture of all products. The Company’s products are sold to local medical practitioners and patients in clinics primarily in the Los Angeles, California area. The Company’s subsidiary is ViaDerma, II Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCPK:VDRM)
New Post
View:
Posts & Comments
Threaded Posts
(0)
•••
exxelero
X
Post by
exxelero
on Jan 14, 2021 10:50am
Great action!!
Glad to see this stock has some action!! Good luck to all those that held! Let's go for 1.00 !!!!
(0)
•••
obliquethesheek
X
Comment by
obliquethesheek
on Feb 28, 2018 5:23pm
RE:when are financials to be released?
should be by the end of march the latest....not sure exact date.....we are excpeting PR soon..
(0)
•••
Crwnryl13
X
Post by
Crwnryl13
on Feb 28, 2018 11:45am
when are financials to be released?
with the sales from vitastem i hope we start to see some action
(0)
•••
Crwnryl13
X
Post by
Crwnryl13
on Feb 07, 2018 3:34pm
anybody looking back at ViaDerma now ?
curious to hear what others are thinking and aproach
(0)
•••
BRENDERR
X
Post by
BRENDERR
on Jul 28, 2017 9:57am
Shouldn't Be Long Now
Shouldn't be long now before this company starts getting some attention. :) ViaDerma, Inc. Starts Phase II of MMJ and Recreational Testing in Canada https://finance.yahoo.com/news/viaderma-inc
...more
(0)
•••
BRENDERR
X
Comment by
BRENDERR
on Jun 15, 2017 8:22am
RE:RE:RE:Worth a Shot
They just started production. Shouldn't be long now :) https://finance.yahoo.com/news/viaderma-inc-commences-first-manufacturing-141813047.html?.tsrc=rss https://finance.yahoo.com/news/viaderma
...more
(0)
•••
Money403
X
Comment by
Money403
on Jun 06, 2017 5:37pm
RE:RE:Worth a Shot
Glad to see someone else on this forum! I'm still holding! Good luck.
(0)
•••
BRENDERR
X
Comment by
BRENDERR
on Jun 06, 2017 8:53am
RE:Worth a Shot
I've been watching and waiting. When the patent issues clear up and production starts (hopefully this month) she's gonna go throuh the roof. :) Expecting +5000 %
(0)
•••
Money403
X
Post by
Money403
on May 03, 2017 11:42am
Worth a Shot
I came across this one by surprise. Doesn't hurt to throw in a 100k shares. Heck, might even add some more at this price. They constantly have activity and news releases. Looking into this one
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >